UBS Group AG
Position in CRL — Charles River Laboratories International, Inc.
CIK 1610520
ZURICH, V8
Position in CRL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$126,177,712
+$48,614,505 QoQ
Shares Held
731,465
+88.1% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.84678692760419.ToString("F0")%
Shared 0.ToString("F0")%
None 2.1532130723958085.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. CRL ranks #12 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,453,453 | $1,205,945,748 | |
| 2 | DHR |
Danaher Corp /De/
|
2,549,143 | $483,317,510 | |
| 3 | WAT |
Waters Corp /De/
|
640,339 | $190,692,952 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
305,167 | $171,470,284 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
340,433 | $163,472,521 | |
| 6 | LH |
Labcorp Holdings Inc.
|
564,529 | $150,621,981 | |
| 7 | ILMN |
Illumina, Inc.
|
1,162,435 | $143,281,736 | |
| 8 | DGX |
Quest Diagnostics Inc
|
702,337 | $137,644,004 |
All Filings in CRL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $126,177,712 | 731,465 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $77,563,207 | 388,827 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $92,742,601 | 592,756 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $111,562,363 | 735,269 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $360,011,477 | 2,391,785 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $61,963,203 | 335,662 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $32,286,529 | 163,916 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $30,251,986 | 146,442 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,824,777 | 121,147 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $22,428,448 | 94,875 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $19,992,310 | 102,012 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $23,308,733 | 110,862 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,899,687 | 108,511 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,401,654 | 84,450 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $10,585,281 | 53,787 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $6,388,286 | 29,856 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $14,915,521 | 52,525 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $30,225,290 | 80,220 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,957,897 | 89,558 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,700,348 | 74,882 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,432,200 | 56,696 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $16,273,381 | 65,130 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $11,154,020 | 49,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,705,982 | 21,256 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $2,763,114 | 21,893 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||